These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38553758)

  • 21. Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study.
    Hasegawa Y; Nakagami T; Oya J; Isago C; Kurita M; Tanaka Y; Ito A; Tsuzura R; Hirota N; Miura J; Uchigata Y
    Diabetol Int; 2019 Jan; 10(1):67-76. PubMed ID: 30800565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Lipidomic Signature of Coronary Heart Disease in American Indian People.
    Miao G; Pechlaner R; Fiehn O; Malloy KM; Zhang Y; Umans JG; Mayr M; Willeit J; Kiechl S; Zhao J
    J Am Heart Assoc; 2024 Feb; 13(3):e031825. PubMed ID: 38293910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes.
    Nwosu BU; Parajuli S; Khatri K; Jasmin G; Al-Halbouni L; Lee AF
    Front Endocrinol (Lausanne); 2021; 12():705565. PubMed ID: 34899592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes.
    Zhang L; Hu Y; An Y; Wang Q; Liu J; Wang G
    Front Endocrinol (Lausanne); 2022; 13():677202. PubMed ID: 35432194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride.
    Jendle J; Hyötyläinen T; Orešič M; Nyström T
    Cardiovasc Diabetol; 2021 Dec; 20(1):237. PubMed ID: 34920733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities.
    Denimal D; Benanaya S; Monier S; Simoneau I; Pais de Barros JP; Le Goff W; Bouillet B; Vergès B; Duvillard L
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3816-e3823. PubMed ID: 35647758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multinational, multi-centre, observational, cross-sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey).
    Andel M; Grzeszczak W; Michalek J; Medvescek M; Norkus A; Rasa I; Niewada M; Kamiński B; Kraml P; Madacsy L;
    Diabet Med; 2008 Oct; 25(10):1195-203. PubMed ID: 19046198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes.
    Nwosu BU; Villalobos-Ortiz TR; Jasmin GA; Parajuli S; Zitek-Morrison E; Barton BA
    J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1399-1408. PubMed ID: 33027052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: Analysis of real-life data from the DPV registry from Germany and Austria.
    Bohn B; Kerner W; Seufert J; Kempe HP; Jehle PM; Best F; Füchtenbusch M; Knauerhase A; Hofer M; Rosenbauer J; Holl RW;
    Diabetes Res Clin Pract; 2016 May; 115():31-8. PubMed ID: 27242120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.
    Guo K; Savelieff MG; Rumora AE; Alakwaa FM; Callaghan BC; Hur J; Feldman EL
    J Clin Endocrinol Metab; 2022 Mar; 107(4):1091-1109. PubMed ID: 34878536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort.
    Andersson Svärd A; Kaur S; Trôst K; Suvitaival T; Lernmark Å; Maziarz M; Pociot F; Overgaard AJ;
    Metabolomics; 2020 Oct; 16(10):109. PubMed ID: 33033923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus.
    Wallace AS; Chang AR; Shin JI; Reider J; Echouffo-Tcheugui JB; Grams ME; Selvin E
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1247-1256. PubMed ID: 35080610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls.
    Canivell S; Rebuffat S; Ruano EG; Kostov B; Sisó-Almirall A; Novials A; Ceriello A; Gomis R
    Diabetes Metab Res Rev; 2015 Feb; 31(2):212-9. PubMed ID: 25139699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of lipid profiles of type 2 diabetes associated with hyperlipidemia using untargeted UPLC Q-TOF/MS-based lipidomics approach.
    Yan L; Han P; Man J; Tian Y; Wang F; Wang J
    Clin Chim Acta; 2021 Sep; 520():53-62. PubMed ID: 34077755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density predictors in long-standing type 1 and type 2 diabetes mellitus.
    Bilha SC; Leustean L; Preda C; Branisteanu DD; Mihalache L; Ungureanu MC
    BMC Endocr Disord; 2021 Aug; 21(1):156. PubMed ID: 34362364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles.
    Ståhlman M; Fagerberg B; Adiels M; Ekroos K; Chapman JM; Kontush A; Borén J
    Biochim Biophys Acta; 2013 Nov; 1831(11):1609-17. PubMed ID: 23896361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes.
    Kostara CE; Karakitsou KS; Florentin M; Bairaktari ET; Tsimihodimos V
    Metabolites; 2022 Jul; 12(8):. PubMed ID: 35893251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes.
    Bennasar-Veny M; Fresneda S; López-González A; Busquets-Cortés C; Aguiló A; Yañez AM
    Nutrients; 2020 May; 12(5):. PubMed ID: 32466178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone Marrow Adiposity Alterations in Type 2 Diabetes Are Sex-Specific and Associated with Serum Lipid Levels.
    Wu PH; Joseph G; Saeed I; Pirmoazen AM; Kenny K; Kim TY; Schafer AL; Schwartz AV; Li X; Link TM; Kazakia GJ
    J Bone Miner Res; 2023 Dec; 38(12):1877-1884. PubMed ID: 37904318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal trends in lipid profile in indian children and youth with type-1 diabetes: a 5-year follow up from a single centre.
    Oza C; Khadilkar A; Mondkar SA; Gondhalekar K; Khadilkar V
    Endocrine; 2023 Feb; 79(2):313-322. PubMed ID: 36414859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.